Friday, August 04, 2017 10:31:32 PM
Yes, stocks trading well below the $6.50 that the street just bought 10 million shares at and even lower than the $6.11 the underwriters of the offering choose to purchase additional shares at.
I'd tend to agree with your last statement. Interesting that million share sell posted after hours today, wonder what that's about? I think you're correct and they're using the "miss" from their quarterly earnings as fuel to drive down the stock and flush out retail. But that's only guessing. I mean they're in a great position now after that offering, plenty of capital to finish other trials and to submit to the EU and FDA.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM